What can Parkinson's disease teach us about COVID-19?

Tipton, Philip W; Wszolek, Zbigniew K

Tipton, Philip W; Wszolek, Zbigniew K.

Tipton PW; Department of Neurology, Mayo Clinic Florida, Jacksonville, USA. tipton.philip@mayo.edu.
Wszolek ZK; Department of Neurology, Mayo Clinic Florida, Jacksonville, USA.

Neurol Neurochir Pol ; 54(2): 204-206, 2020.

Article in English | MEDLINE | ID: covidwho-108972

Subject(s)

Betacoronavirus; Coronavirus Infections/complications; Parkinson Disease; Pneumonia, Viral/complications; Antiparkinson Agents; COVID-19; Humans; Levodopa; Pandemics; Parkinson Disease/complications; SARS-CoV-2

Keywords

COVID-19; Parkinson's disease; amantadine; memantine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Parkinson Disease / Pneumonia, Viral / Coronavirus Infections / Betacoronavirus Topics: Long Covid Limits: Humans Language: English Journal: Neurol Neurochir Pol Year: 2020 Document Type: Article Affiliation country: PJNNS.a2020.0039

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google